8:00 am Registration Open & Coffee Networking
8:30 am Chair’s Opening Remarks
8:45 am Exploring the Current NK Landscape
Synopsis
Download the full event guide to find out more on session details
9:30 am Keynote Panel Discussion: Reigniting Pharma & Investor Interest in NK Cell Therapies
Synopsis
Download the full event guide to find out more on session details
10:00 am Lead Partner Presentation: Miltenyi Biotec
10:30 am Morning Refreshments & Speed Networking
Preclinical
Transforming Cell Engineering for Functional Advancements
11:30 am AlloNK® as an ADCC Enhancer
Synopsis
Download the full event guide to find out more on session details
11:30 am Modifying NK cells through Genetic Engineering to Enhance Their Persistence and Functionality
12:00 pm Engineering NK Cells for Combinational Therapies
Synopsis
Download the full event guide to find out more on session details
12:00 pm Engineering CAR constructs for NK Cells
12:30 pm Audience Led Discussion: NK Engagers vs NK Cell Therapies
Synopsis
Download the full event guide to find out more on session details
Clinical Translation
Streamlining Clinical Trial Design for Improved Targeting of the TME & Overall Faster Phase Development Success
11:30 am The Unique Challenges of Translating ProtoNK Therapies into Clinical Success
Synopsis
Download the full event guide to find out more on session details
12:00 pm A Sanofi Case Study: Designing a Robust Clinical Design & Evaluation Strategy to Enter the Clinic
Synopsis
Download the full event guide to find out more on session details
12:30 pm Audience Led Discussion: Overcoming Unique Challenges of Clinical Trial Designs for Streamlined Entry into the Clinic
CMC & Process Development
Ensuring Safety and Efficiency in Gold Standard Manufacturing Practices
11:30 am Bringing A MAGE-A4 Targeting “Off the Shelf” TCR-NK Cells Into the Clinic: Leveraging Pre-Clinical And Manufacturing Interplay
Synopsis
Download the full event guide to find out more on session details
12:00 pm Pooled Donor Manufacturing for Highly Scalable Generation of Potent NK Cells
Synopsis
Download the full event guide to find out more on session details
12:30 pm Program Partner Presentation by Militenyi Biotec
Synopsis
Download the full event guide to find out more on session details
1:00 pm Lunch & Networking
Understanding Novel Technologies within NK Cells to Produce of “Well-Behaving” NK cells
2:00 pm Novel Technologies to Produce Highly Cytotoxic NK Cells Using CD34+ Cord Blood Cells
Synopsis
Download the full event guide to find out more on session details
2:30 pm Building Polyvalent NK Cell Engagers for Enhanced Tumor Targeting and Therapeutic Efficacy
Synopsis
Download the full event guide to find out more on session details
Streamlining Clinical Trial Design for Improved Targeting of the TME & Overall Faster Phase Development Success
2:00 pm Engineered NK-92 (aNKTM) Cells – Preclinical & Clinical Results
Synopsis
Download the full event guide to find out more on session details
2:30 pm Gene Editing Strategies to Enhance CAR-NK Cell Function in The Solid Tumor Microenvironment
Synopsis
Download the full event guide to find out more on session details
Elevating Live Cell Manufacturing Efficiency and Quality Through Feeder & Non-Feeder Cell Technologies
2:00 pm Investigating the Benefits of Feeder-Free NK Cell Expansion
Synopsis
Download the full event guide to find out more on session details
2:30 pm Expanding Cytokine Induced Memory Like (CIML) NK Cells Using Feeder Cell Technology
Synopsis
Download the full event guide to find out more on session details
3:00 pm Afternoon Refreshments & Poster Session
4:00 pm Roundtable: Engineering Well Behaving NK Cells for Enhanced Therapeutic Efficacy
Synopsis
Download the full event guide to find out more on session details
4:30 pm An Update on Immune Bridge’s Non-Engineered NK Cell Therapy
Synopsis
Download the full event guide to find out more on session details
4:00 pm Fireside chat: Bispecific Antibodies and AI Machine Learning
Synopsis
Download the full event guide to find out more on session details
4:30 pm Cytovia Therapeutics Presents New Data on CD38 & CD30 NK Cells
Synopsis
Download the full event guide to find out more on session details
4:00 pm Roundtable: Optimizing Expansion Strategies for Enhanced Therapeutic Impact
Synopsis
Download the full event guide to find out more on session details
4:30 pm An Introduction into Mendus’s NK Cell Platform
Synopsis
Download the full event guide to find out more on session details